3Pram MP, de Diego JI, Fernandez - Zubillaga A, et al. Patencyand flow of the internal vein after functional neck dissection. La- ryngoscope, 2000,110 ( 1 ) :47 - 50.
4Weymuller EA, Yueh B, Deleyiannis FW, et al. Quality of life in patients with head and neck cancer: lessons learned form 549 prospectively e':aluated patients. Arch Otolaryngol Head Neck Surg, 2000,126 (3) : 329 - 336.
5Schwartz S, Patrick DL, Yueh B. Quality - of - life outcomes in the evaluation of head and neck cancer treatments. Arch Otolaryn- gol Head Neck Surg,2001,127 (6) :673 -678.
7Bjordal K, Ahlner - Elmqvist M, Hammerlid E, et al. A prospec- tive study of quality of life in head and neck cancer patients. Par- tlI : Longitudinaldata. Laryngoscope ,2001,111 (8) : 1440 - 1452.
8Campbell BH, Marbella A, Layde PM. Quality of life and recur- rencn in survivors of head and neck cancer. Laryngoscope, 2000, 110(6) :895 -906.
2[1]Robins KT,Medina JE,Wolfe GT,et al.Standardizing neck dissection terminology:Official report of the academy's ccommittee for head and neck surgery.and oncology.Arch Otolaryngol Head Neck Surg,1991,117:601.
3[2]Robins KT. Classification of neck dissection: Current concepts and future considerations.Otolaryngol Clin North Am.1998,31(40):639.
4[3]Medina JE .A rationale classification of neck dissections.Otolaryngol Head Neck Surg,1989,(100):169.
5[4]Breau RL,Suen JY.Management of N0 neck.Otolaryngol Clin North Am,1998,31(40):635.
6[5]Medina JE, Byers RM.Surpaomohyoid ndck dissection:rationale,indications,and surgical technique.Head Neck,1989,11:111.
7[6]Byers RM, Clayman GL, McGill D,et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive rtact:patterns of regional failure.Head Neck,1999,21:499.
8[7]Byers RM,Weber RS,Andrewx T,et al.Frequency and therapeutic implications of "skipmetastases" in the neck from squamous carcinoma of the oral tongue.Head Neck,1997,19:14.
9[8]Pitman KT,Johnson JT,Myers EN.Effectiveness of selective neck dissection for management of the clinically negative neck.Arch Otolaryngol Head Ncek Surg,1997,123:917.
10[9]Kerrebijn JD,Freeman JL,Irish JC,et al. Supraomohyoid neck dissection.Is it diagnostic or therapeutic?Head Neck,1999,21:39.
1Ducic Y, Oxford L. Transcervical elective superior mediastinal dissection for thyroid carcinoma [J]. Am J Otolaryngol, 2009,30 ( 4 ) : 221-224.
2Vethakkan SR,Roberts V,Ward GM. Sudden onset of haemoptysis and hypoxia after recombinant human thyroid-stimulating hormone use in a patient with papillary thyroid carcinoma and pulmonary metastases [J]. Intern Med J, 2009,39 ( 12 ) : 854-855.
3Rosario PW,Borges MA,Purisch S. Preparation with recombinant hu- man thyroid-stimulating hormone for thyroid remnant ablation with 1311 is associated with lowered radiotoxicity [J]. J Nucl Med, 2008,49 (11 ): 1776-1782.
4Dequanter D,Lothaire P. Incidental metastases of well-differentiated thyroid carcinoma in lymph nodes of patient with squamous cell head and neck cancer: case report with review of the literature [J]. Rev Med Brux, 2008,29 (5) :487-489.
5Randolph GW,Pearce EN. Surgery of well-differentiated thyroid carci- noma:the pendulum swings back in the central neck [J]. Endocr Pract, 2010,16(5) :913-917.
6Doi SA,Woodhouse NJ,Thalib L,et al. Ablation of the thyroid remnant and 1-131 dose in differentiated thyroid cancer:a meta-analysis revisit- ed [J]. Clin Med Res,2007,5(2):87-90.
7Ahn BC,Lee SW,Lee J. Multistage high-dose 1-131 treatment for a nonthyroidectomized patient with metastatic differentiated thyroid cancer [J]. Clin Nucl Med, 2011,36 (12) : 224-227.
